Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.
Clinical trial NCT03453112 · COMPLETED
Trial details
- NCT number
- NCT03453112
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2021-12-28
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.